vimarsana.com

Page 7 - சீனா தினசரி ஆசியா செய்தி வலைப்பின்னல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

China approves Sinopharm vaccine for children, teenagers

Women and a child walk by a billboard calling on people to get vaccinated against Covid-19 outside a shopping mall in Beijing, capital of China, on May 24, 2021. - AP BEIJING (China Daily/ANN): Sinopharm s Covid-19 vaccine has been approved for emergency use for young people ages 3 to 17, after early and midstage clinical trials showed it is safe and can elicit strong immune responses in the age group, the company said in a recent statement. The approval was granted by the Joint Prevention and Control Mechanism of the State Council, which was set up to deal with the Covid-19 pandemic. It is the second domestic Covid-19 vaccine made available for children and teenagers in China. In June, Sinovac Biotech s vaccine was authorised for emergency use for young people.

Study in China finds Covid-19 antibodies last at least 12 months

This handout illustration image obtained on Feb 27, 2020, courtesy of the National Institutes of Health, shows a transmission electron microscopic image showing SARS-CoV-2 also known as 2019-nCoV, the virus that causes Covid-19. BEIJING (China Daily/ANN): Antibodies against the novel coronavirus can last for at least 12 months in more than 70 per cent of recovered Covid-19 patients, a study published by Chinese researchers on Tuesday (July 6) shows. The finding adds to growing evidence that vaccination, which elicits an immune response in a way similar to how a live virus triggers human bodies to generate antibodies, can effectively restrict the spread of SARS-CoV-2 , the study said, referring to the novel coronavirus that causes Covid-19.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.